Literature DB >> 11848628

The predictive value of laboratory findings in patients with primary hyperparathyroidism.

Géza Mózes1, Kathleen J Curlee, Charles M Rowland, Jon A van Heerden, Geoffrey B Thompson, Clive S Grant, David R Farley.   

Abstract

BACKGROUND: Despite extensive preoperative imaging and intraoperative "gadgetry" to facilitate localization of abnormal parathyroid glands, the onus of identification and resection remains with the surgeon in the operating room. We pondered the relative usefulness of routine laboratory studies to the surgeon as predictive guides to the intraoperative findings in patients with primary hyperparathyroidism (HPT). STUDY
DESIGN: Pre- and postoperative laboratory data were analyzed in 166 consecutive patients (1998 to 1999) undergoing successful cervical exploration for sporadic primary HPT and were correlated with the pathologic findings. Patients with secondary HPT, multiple endocrine neoplasia, familial HPT, and parathyroid carcinoma were not included in this study.
RESULTS: One hundred eighteen women and 48 men (mean age = 63 years) with parathyroid adenoma (n = 155) and sporadic hyperplasia (n = 11) were evaluated. Mean parathormone (PTH) levels varied little with the pathology: adenoma = 9.6 pmol/L and hyperplasia = 10.2 pmol/L (p > 0.05). In patients with parathyroid adenoma, analysis of preoperative measures showed a positive correlation (r = 0.48, p < 0.0001) with PTH and gland weight. The correlation appeared to be the strongest in the tails of the distribution; in 22 of 23 (96%) cases with PTH levels lower than 6 pmol/L, the offending lesion or lesions were less than 400 mg; in all six cases with PTH levels higher than 18.0 pmol/L, the abnormal gland or glands weighed more than 800 mg. PTH levels between 6 and 18 pmol/L revealed mean adenoma weight of 757 mg (median = 420 mg; range = 50 to 5,500 mg).
CONCLUSIONS: Extreme values of PTH in patients with single-gland parathyroid disease alert the surgeon to the likelihood of small or large parathyroid adenomas. Laboratory studies do not differentiate adenoma from hyperplasia, nor do they pinpoint the size of abnormal glands with moderate-range PTH values.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11848628     DOI: 10.1016/s1072-7515(01)01139-5

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  21 in total

1.  Sestamibi SPECT intensity scoring system in sporadic primary hyperparathyroidism.

Authors:  Linwah Yip; Daniel A Pryma; John H Yim; Sally E Carty; Jennifer B Ogilvie
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

2.  Predictors of intra-operative parathyroid hormone decline in subjects operated for primary hyperparathyroidism by minimally invasive parathyroidectomy.

Authors:  M-H Gannagé-Yared; B Abboud; M Amm-Azar; A Saab; S Khalife; G Halaby; C Atallah; R Medlej; S Jambart
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

3.  Changing biochemical presentation of primary hyperparathyroidism.

Authors:  Martin Almquist; Anders Bergenfelz; Hans Mårtensson; Mark Thier; Erik Nordenström
Journal:  Langenbecks Arch Surg       Date:  2010-07-10       Impact factor: 3.445

Review 4.  A meta-analysis comparing the biochemistry of primary hyperparathyroidism in youths to the biochemistry of primary hyperparathyroidism in adults.

Authors:  Jeffrey Roizen; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

5.  The small abnormal parathyroid gland is increasingly common and heralds operative complexity.

Authors:  Kelly L McCoy; Naomi H Chen; Michaele J Armstrong; Gina M Howell; Michael T Stang; Linwah Yip; Sally E Carty
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

6.  Surgical treatment of patients with mildly elevated parathormone and calcium levels.

Authors:  Punam P Parikh; Bassan J Allan; John I Lew
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

7.  The value of intraoperative PTH measurements in patients with mild primary hyperparathyroidism.

Authors:  Thomas D Hathaway; Gareth Jones; Michael Stechman; David Scott-Coombes
Journal:  Langenbecks Arch Surg       Date:  2013-04-26       Impact factor: 3.445

8.  Challenging neck mass: non-functional giant parathyroid adenoma.

Authors:  Chiara Mossinelli; Alberto Maria Saibene; Loredana De Pasquale; Alberto Maccari
Journal:  BMJ Case Rep       Date:  2016-08-17

9.  Correlation of biochemical markers of primary hyperparathyroidism with single adenoma weight and volume.

Authors:  F Kamani; A Najafi; S S Mohammadi; S Tavassoli; S P Shojaei
Journal:  Indian J Surg       Date:  2012-03-27       Impact factor: 0.656

10.  Machine learning to identify multigland disease in primary hyperparathyroidism.

Authors:  Joseph R Imbus; Reese W Randle; Susan C Pitt; Rebecca S Sippel; David F Schneider
Journal:  J Surg Res       Date:  2017-06-29       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.